- Location advantages
- Life Sciences
- Research & development
Octapharma is further expanding its Viennese facility and investing € 200 million
In 1989, the first production plant of the family-run company Octapharma was put into operation in Vienna. Today the globally operating firm headquartered in Switzerland is the world’s largest independent plasma fractionator and a leader in the field of developing and manufacturing high-quality human proteins from human plasma and human cell lines. The facility in Vienna employing a staff of 1,400 people and bundling production, research and development plays a key role in this regard, and Octapharma is now strongly expanding this production site.
Octapharma plans to invest € 200 million in its Viennese facility over the next five years. An important piece of the puzzle is construction of a new so-called oat grain hall. This expansion drive is designed to considerably improve the global supply of essential plasma products to patients based on the family-run pharmaceutical company’s expecting increasing demand in the years to come.
“We are pleased to be able to further expand what has become the historic production plant in Vienna and create the possibility for further growth. In this way we can supply patients across the globe with our products more effectively and in greater volumes,” explains Barbara Rangetiner, Managing Director of Octapharma Austria. “Moreover, we are also providing an important boost to Austria as a pharmaceutical location to stimulate domestic production and globally improve the supply of pharmaceuticals.”
United Micro Develops 5G Modem Chips in Austria for IoT
High-frequency microchips are manufactured in Linz, Upper Austria, a RF chip development hotspot for mobile telephony and radar.
Deep Tech Startup Godot Inc. opened a research and development hub in Austria02. November 2023
Godot Inc. was established in July 2022 in Kobe, Japan as a DeepTech Startup focusing on behavioural change for good. As an impact startup, Godot aims to address the cognitive limitations that people commonly face. Individuals frequently encounter difficulties in making optimal decisions due to constraints in cognition and the decision-making processes.